Hainan Haiyao: Plans to reduce holdings in China Antibody by no more than 5% of shares

2026-04-05 11:54:23

People’s Finance Information, April 3—Hainan Haiyao (000566) announced on April 3 that the company plans to reduce its holdings of shares in China Antibody Pharmaceutical Co., Ltd. (hereinafter referred to as “China Antibody”) through centralized bidding transactions and block trades. The number of shares to be reduced will not exceed 68 million shares (representing no more than 5% of its total share capital).

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes